Agenda

We would like to thank our exhibitors and sponsors for sponsoring this meeting which includes pharmaceutical companies including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Monday, November 25, 2024
9:20 AM - 10:15 AM
Chair's opening remarks followed by: Managing pulmonary hypertension as an MDT
  • Diagnostic challenges and the role of imaging technology 

  • Integrating cardiology and pulmonology treatment plans 

  • How to best work together for the benefit of the patient  

 
 
10:25 AM - 11:10 AM
Transforming COPD care - optimising COPD maintenance therapy in secondary care: Interventions in secondary care to improve patient outcomes
 
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
Transforming COPD care - optimising COPD maintenance therapy in secondary care: Interventions in secondary care to improve patient outcomes
11:20 AM - 12:05 PM
Rethinking severe asthma: Innovations in management and patient outcome
 
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
Rethinking severe asthma: Innovations in management and patient outcome
12:05 PM
Chair change over
 
 
 
 
12:15 PM - 1:00 PM
Lung cancer – management and diagnosis: NICE guidance
  • The importance of early diagnosis – indications for chest radiotherapy   

  • Helping patients to understand what is available for them and what their risk factors are   

  • Effectiveness of diagnostic and staging investigations 

 
 
1:10 PM - 1:55 PM
What should we know about sleep-disordered breathing (SDB)
  • Identifying types of SDB and diagnosing patients correctly 

  • Surgery options and what is used across the UK and EU 

  • Common side effects and risks for those with SDB disorders 

 
 
2:05 PM - 2:55 PM
Severe respiratory disease challenges & management (ERS guideline discussion)
  • Discuss the challenges of respiratory care & severe lung disease
  • Discuss European Respiratory Society (ERS) advanced symptom management guideline ’24
  • Discuss implications for practice
 
 
2:50 PM
End of conference
 
 
 
 

Speakers


Helena Beer
Editor, Hospital Healthcare Europe, Hospital Pharmacy Europe, Cogora

Dr Alanna Hare
President, British Sleep Society, Treasurer, British Thoracic Society Consultant Physician, Department of Sleep and Ventilation, Royal Brompton and Harefield Hospitals

David Kiely
Consultant Respiratory Physician, Professor of Pulmonary Vascular Medicine, Sheffield Teaching Hospitals NHS Foundation Trust

Zaheer Mangera
Respiratory Consultant, Lung Cancer Lead, North Middlesex University Hospital NHS Trust

Colm McCabe
Respiratory Consultant in Pulmonary Hypertension, Royal Brompton Hospital

Heba Nashat
Consultant Cardiologist in Pulmonary Hypertension, Royal Brompton Hospital

Ravijyot Saggu
Respiratory and Medicines Optimisation Pharmacist, UKCPA Respiratory Committee Chair, Clinical Member, NHSE Respiratory Clinical Reference Group

Ajit Thomas
Consultant Respiratory Physician, University Hospitals of North Midlands NHS Trust

Dr Ernie Wong
Consultant Respiratory Physician with Specialist Interest in Asthma and Chronic Obstructive Pulmonary Disease (COPD, Clinical Lead for Asthma, Imperial College Healthcare NHS Trust